IN2014MU00328A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00328A
IN2014MU00328A IN328MU2014A IN2014MU00328A IN 2014MU00328 A IN2014MU00328 A IN 2014MU00328A IN 328MU2014 A IN328MU2014 A IN 328MU2014A IN 2014MU00328 A IN2014MU00328 A IN 2014MU00328A
Authority
IN
India
Prior art keywords
drug
dissolution
nanocrystal
bioavailability
crystallized
Prior art date
Application number
Inventor
Kumar Guntamukkala Santosh
Satyanarayan Pattnaik
Kalpana Swain
Venkateshwar Rao Jupally
Baikuntha Prusty Korada
Sanjeev Kumar Subudhi
Original Assignee
Kumar Guntamukkala Santosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumar Guntamukkala Santosh filed Critical Kumar Guntamukkala Santosh
Priority to IN328MU2014 priority Critical patent/IN2014MU00328A/en
Publication of IN2014MU00328A publication Critical patent/IN2014MU00328A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to nanocrystal of hydrophobic drugs with low solubility to enhance solubility thereby to improve the dissolution, absorption and bioavailability. The invention provides nanoscopic drug crystals of average particle size less than 1 mm in semi crystalline or partially amorphous or amorphous form, re-crystallized from drug solution in presence of stabilizer. The invention is further directed to cost effective process of preparing, processing parameters, physical characteristics, better dissolution, compositions and method of use of drug nanocrystals.
IN328MU2014 2014-01-30 2014-01-30 IN2014MU00328A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN328MU2014 IN2014MU00328A (en) 2014-01-30 2014-01-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN328MU2014 IN2014MU00328A (en) 2014-01-30 2014-01-30

Publications (1)

Publication Number Publication Date
IN2014MU00328A true IN2014MU00328A (en) 2015-09-11

Family

ID=54393678

Family Applications (1)

Application Number Title Priority Date Filing Date
IN328MU2014 IN2014MU00328A (en) 2014-01-30 2014-01-30

Country Status (1)

Country Link
IN (1) IN2014MU00328A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021008652A1 (en) * 2019-07-15 2021-01-21 MyBiotech GmbH Nanostructured ibuoprofen compositions, methods for their preparation, and pharmaceutical composition containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021008652A1 (en) * 2019-07-15 2021-01-21 MyBiotech GmbH Nanostructured ibuoprofen compositions, methods for their preparation, and pharmaceutical composition containing them

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
PH12015501648A1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12016502378A1 (en) Substituted dihydroisoquinolinone compounds
MX2017001281A (en) Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof.
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12017502155A1 (en) Formation of cyclosporin a/cyclodextrin nanoparticles
MX355330B (en) CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS and USES THEREOF.
WO2016011049A3 (en) Compositions and methods for disease treatment using nanoparticle delivered compounds
MY190283A (en) Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
WO2014131422A3 (en) Fermented rapeseed feed ingredient
MX2016011358A (en) Liquid lactase compositions.
NZ735736A (en) Acetate salt of buprenorphine and methods for preparing buprenorphine
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
NZ704092A (en) Ph adjusted pulse protein product
MX370488B (en) Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli.
SG10201909412RA (en) Composition for suppressing muscular fatty change
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
IN2014MU00328A (en)
PH12015502820A1 (en) Nanoparticulate formulation comprising a trpa1 antagonist
WO2015074667A3 (en) Composition for dermatitis
NZ728136A (en) Method for producing aqueous ophthalmic composition, and aqueous ophthalmic composition
IN2013MU03610A (en)
IN2013CH04330A (en)
PL407710A1 (en) Method for producing the eye drops preparation in the form of a suspension containing brinzolamidum and the preparation produced by this method
PL406213A1 (en) Hydrocolloid nanocomposite and method for producing it